StockData
Harvard Bioscience Inc logo

Harvard Bioscience Inc (HBIO) stock

HBIONasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 3/3040% above fair value
$9.08+0.17 (+1.91%)

Close on Nov 17, 2026Market cap $41.33MP/E –Yield –

Harvard Bioscience operating margin

Operating margin is operating income as a percentage of revenue.

Harvard Bioscience's operating margin for the twelve months ending Jun 30, 2026 was -0.3%. For fiscal 2025 it was -56.1%, against -6.6% the year before. The highest annual figure on record is 9.4% in fiscal 2010.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-56.1%−49.5
FY2024Dec 31, 2024-6.6%−8.3
FY2023Dec 31, 20231.7%+7.8
FY2022Dec 31, 2022-6.1%−7.9
FY2021Dec 31, 20211.7%+1.5
FY2020Dec 31, 20200.2%−0.1
FY2019Dec 31, 20190.3%−0.5
FY2018Dec 31, 20180.8%+1.6
FY2017Dec 31, 2017-0.8%+2.0
FY2016Dec 31, 2016-2.9%−1.3
FY2015Dec 31, 2015-1.6%−7.7
FY2014Dec 31, 20146.1%+4.6
FY2013Dec 31, 20131.5%−5.6
FY2012Dec 31, 20127.0%−0.7
FY2011Dec 31, 20117.7%−1.7
FY2010Dec 31, 20109.4%+0.1
FY2009Dec 31, 20099.4%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-4.3%−0.3
Q1 FY2026Mar 31, 2026-5.7%+222.5
Q4 FY2025Dec 31, 20257.2%+7.2
Q3 FY2025Sep 30, 20251.0%+9.5
Q2 FY2025Jun 30, 2025-4.0%+5.0
Q1 FY2025Mar 31, 2025-228.1%−218.8
Q4 FY2024Dec 31, 20240.0%−1.0
Q3 FY2024Sep 30, 2024-8.5%−4.9
Q2 FY2024Jun 30, 2024-9.0%−11.7
Q1 FY2024Mar 31, 2024-9.3%−15.1
Q4 FY2023Dec 31, 20231.0%+2.6
Q3 FY2023Sep 30, 2023-3.7%+10.3
Q2 FY2023Jun 30, 20232.8%−10.9
Q1 FY2023Mar 31, 20235.8%+29.2
Q4 FY2022Dec 31, 2022-1.6%−6.7
Q3 FY2022Sep 30, 2022-14.0%−15.8
Q2 FY2022Jun 30, 202213.7%+13.5
Q1 FY2022Mar 31, 2022-23.3%−22.4
Q4 FY2021Dec 31, 20215.1%−3.8
Q3 FY2021Sep 30, 20211.8%+1.1
Q2 FY2021Jun 30, 20210.2%−2.2
Q1 FY2021Mar 31, 2021-0.9%+12.9
Q4 FY2020Dec 31, 20208.9%+3.6
Q3 FY2020Sep 30, 20200.8%+5.7
Q2 FY2020Jun 30, 20202.4%+1.6
Q1 FY2020Mar 31, 2020-13.8%−13.3
Q4 FY2019Dec 31, 20195.3%+0.1
Q3 FY2019Sep 30, 2019-5.0%−8.1
Q2 FY2019Jun 30, 20190.8%+2.0
Q1 FY2019Mar 31, 2019-0.4%+4.3
Q4 FY2018Dec 31, 20185.1%+3.4
Q3 FY2018Sep 30, 20183.1%+5.2
Q2 FY2018Jun 30, 2018-1.2%+0.2
Q1 FY2018Mar 31, 2018-4.7%−2.8
Q4 FY2017Dec 31, 20171.7%+6.0
Q3 FY2017Sep 30, 2017-2.1%+1.2
Q2 FY2017Jun 30, 2017-1.4%–
Q1 FY2017Mar 31, 2017-1.9%–
Q4 FY2016Dec 31, 2016-4.3%–
Q3 FY2016Sep 30, 2016-3.3%–

More Harvard Bioscience figures

See a number that looks wrong?